key: cord-0805872-erkhfhai authors: Agarwal, Nitish; Raheja, Amol; Suri, Ashish title: Guidelines for Preoperative Testing for Neurosurgery in COVID-19 Era: Indian Viewpoint Amidst Global Practice date: 2020-10-24 journal: World Neurosurg DOI: 10.1016/j.wneu.2020.10.086 sha: 2e479d7c6adca10e2784971640eaf13e7f4ab8b6 doc_id: 805872 cord_uid: erkhfhai Preoperative testing and evaluation for Coronavirus disease (COVID-19) has been an enigmatic challenge for the neurosurgical community during the pandemic. Since the beginning of the pandemic, laboratory diagnostic methods have evolved substantially, and with them has the necessity for readily available, fast and accurate preoperative testing methods. In this article, we provide an overview of the various laboratory testing methods which are presently available and a comprehensive literature review how various institutes and neurosurgical communities across the globe are employing them to ensure safe and effective delivery of surgical care to patients. Through this review, we highlight the guiding principles for preoperative testing, which may serve as a road map for other medical institutions to follow. Additionally, we provide an Indian perspective of preoperative testing and share our experience in this regard. 1 Introduction 19 to be interpreted with caution considering clinical features, radiological findings and even 47 repeat testing in cases with strong clinical suspicion of 5, 9 48 According to WHO and US Centers for Disease Control and Prevention (CDC) the 49 recommended sample for initial COVID-19 testing is upper respiratory specimen 50 (Nasopharyngeal swab, Oropharyngeal swab or wash in ambulatory patients) and/or lower 51 respiratory specimen in patients with more severe respiratory disease (endotracheal aspirate, CoV-2 virus (strain) respectively. TrueNAT system has been previously used as a rapid, 100 portable, POC and cost effective test for diagnosis of tuberculosis within primary healthcare 101 facilities and has proven more cost effective than smear microscopy or Xpert. 27-29 ICMR 102 recommends TrueNAT test as a two-step test: step one comprises E gene (which helps build 103 the envelope) screening assay (TrueNAT Beta CoV) for all suspected COVID-19 samples 104 followed by step two for the RdRp gene (RNA dependant RNA polymerase) based 105 confirmatory test (TrueNAT SARS-CoV-2) in all samples testing positive for E gene. The 106 samples testing negative from step one and those testing positive from step two are to be 107 considered as true negatives and true positives respectively and no further RT-PCR based 108 confirmation is required in such a scenario. 19 Research evidence regarding spread of COVID-19 by asymptomatic carriers is still limited. However, studies suggest that the potential of asymptomatic and pre-symptomatic individuals A review of the articles on PubMed was carried out using keywords-"COVID-19" and 207 "neurosurgery" on June 15, 2020. The search yielded 351 articles which were reviewed for 208 relevance. References from relevant articles were reviewed to locate other articles of interest. From this data, we were able to compile a review of preoperative testing protocols of 19 210 different institutes in 11 different countries around the world (Table 2) . 54-74 Additionally, 211 documents published on webpages of various international neurosurgical societies and 212 consensus statements from various neurosurgical institutes were also noted (Table 3) (Table 2 and Table 3 ). RT-PCR using a nasopharyngeal or a throat swab was found to be the 216 most widely used method for preoperative screening and diagnosis. As the testing capacity Zitek T. Table 3 . Literature review of recommendations on preoperative testing: Professional bodies 539 540 J o u r n a l P r e -p r o o f Assa'ad A. Clinical testing for COVID-19 Laboratory testing of SARS-CoV, MERS-CoV, and SARS-CoV-2 312 (2019-nCoV): Current status, challenges, and countermeasures Current laboratory diagnostics of coronavirus disease 315 2019 (COVID-19) Detection of SARS-CoV-2 in Different Types of Clinical 336 Upper respiratory tract sampling in COVID-338 Laboratory Diagnosis of COVID-19: Current 340 Diagnostic Testing for Severe Acute Respiratory 342 Syndrome-Related Coronavirus 2: A Narrative Review An evolving approach to the laboratory assessment of COVID-344 19 Laboratory diagnosis of emerging human coronavirus infections -346 the state of the art Potential Rapid Diagnostics, Vaccine and Therapeutics for 348 2019 Novel Coronavirus (2019-nCoV): A Systematic Review Information for COVID-19 Testing Labs Cartridge-based nucleic acid 352 amplification test: a novel rapid diagnostic tool to study the burden of tuberculosis from a 353 tertiary care hospital Sputum Samples by Cepheid Xpert Assay: A Clinical Study CBNAAT: A Boon for Early Diagnosis of Tuberculosis-Head and 358 A prospective study evaluating the impact of cartridge-based nucleic 360 acid amplification test (CBNAAT) on the management of tuberculosis in a low-resource high-361 burden Indian rural setting 55. Coronavirus in the U.S.: Latest Map and Case Count -The New York Times: Available Pandemic Recovery Using a COVID-Minimal 444 Neurosurgical management of brain and spine tumors 446 in the COVID-19 era: an institutional experience from the epicenter of the pandemic Safety Considerations for Neurosurgical Procedures During the COVID-19 Pandemic Academic Neurosurgery Department 451 Response to COVID-19 Pandemic: The University of Miami/Jackson Memorial Hospital 452 COVID-19 Preoperative Assessment and Testing From Surge to Recovery Pre-operative COVID-19 testing and decolonization 457 Managing care for 459 patients with sinonasal and anterior skull base cancers during the COVID-19 pandemic. Head 460 Neck Hub and Spoke' Lombardy Neurosurgery Group. May we 462 deliver neuro-oncology in difficult times (e.g. COVID-19) Neurosurgery in the storm of COVID-19: 465 suggestions from the Lombardy region, Italy (ex malo bonum) How Neurosurgeons Are Coping with COVID-19 and How It Impacts 468 Preliminary Recommendations for Surgical Practice of 471 Neurosurgery Department in the Central Epidemic Area of 2019 Coronavirus Infection Experiences of practicing surgical neuro-oncology during the 474 COVID-19 pandemic How SARS-CoV-2 is forcing us to 476 reconsider and reorganize our daily neurosurgical practice A safe approach to surgery for pituitary and skull base 479 lesions during the COVID-19 pandemic An Exit Strategy for Resuming 481 Nonemergency Neurosurgery after Severe Acute Respiratory Syndrome Coronavirus 2: A 482 United Kingdom Perspective SARS-CoV-2) in patients planned for surgery -continuing the service and 485 'suppressing' the pandemic COVIDSurg Collaborative. Global guidance for surgical care during the COVID-19 pandemic 487 Neurosurgical Patients' Management During the COVID-19 Pandemic-An Institutional Report 490 From an African Neurosurgical Center Endonasal neurosurgery during the COVID-19 492 pandemic: the Singapore perspective POC: Point of care 10. RNA: Ribonucleic Acid 11. RT-PCR: Reverse Transcription-Polymerase Chain Reaction 12 J o u r n a l P r e -p r o o f We wish to confirm that there are no known conflicts of interest associated with this publication and there has been no significant financial support for this work that could have influenced its outcome.We confirm that the manuscript has been read and approved by all named authors and that there are no other persons who satisfied the criteria for authorship but are not listed. We further confirm that the order of authors listed in the manuscript has been approved by all of us.We confirm that we have given due consideration to the protection of intellectual property associated with this work and that there are no impediments to publication, including the timing of publication, with respect to intellectual property. In so doing we confirm that we have followed the regulations of our institutions concerning intellectual property.We understand that the Corresponding Author is the sole contact for the Editorial process (including Editorial Manager and direct communications with the office). He is responsible for communicating with the other authors about progress, submissions of revisions and final approval of proofs. We confirm that we have provided a current, correct email address which is accessible by the Corresponding Author and which has been configured to accept email from the World Neurosurgery journal.